Oncode Accelerator Annual Event

Over 130 experts across different fields in oncology drug development joined the two day Oncode Accelerator event where each Workstream and Platform had a chance to share their work. Furthermore, there was plenty of room to discuss how together we can accelerate the development of new therapies that fit one of four common drug types; small molecules, biologics, therapeutic vaccines and cell and gene therapy while placing the patient at the centre through new innovations such as AI, organoids and well-defined patient cohorts.

We left the meeting with great excitement and have continued discussions on Demonstrator Projects, which serve to validate our innovative approach and integrated infrastructure, and are keen to onboard new partners and demonstrators to join next steps in our journey towards outsmarting cancer and impacting lives.